Nasdaq

Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit

23-01-2026

Not for dissemination in the United States of America

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that its wholly-owned subsidiary, Assured Diagnosis Inc. ("ADI"), has signed a broker agreement (the "Agreement") with Greatway Financial Inc. ("Greatway"), an Insurance Managing General Agency licensed across Canada. Pursuant to the Agreement, Greatway will be authorized to market and solicit enrollments for ADI's MyCare Ally program in every province of Canada, except Quebec. Greatway anticipates launching its marketing initiatives for GOeVisit on February 7, 2026.

MyCare Ally is a full-spectrum healthcare support service that provides personalized assistance and access to medical care for individuals and families. The service includes initial diagnosis assistance by qualified healthcare professionals, independent clinical reviews, treatment summaries, virtual medical care through GOeVisit provided by licensed physicians, diagnostic imaging coordination and access to a secure digital health information portal.

Electronic Medical Records Software for GOeVisit

The Company also announces that its wholly-owned subsidiary, Aja Health Inc., will be moving GOeVisit, its platform to deliver customer-focused virtual health consultations, to a new Electronic Medical Records ("EMR") software system. The new EMR software will provide increased functionality to expand services through GOeVisit to provide monitored programs, including the GLP-1 initiative for weight management, lab requisition services, and expanded virtual testing services. It is expected that the GOeVisit platform will move to the new EMR software on January 28, 2026.

On behalf of the Board of Directors

"Sanjeev Parsad"

Sanjeev Parsad
President, CEO and Director

The above may contain "forward-looking information" within the meaning of applicable securities laws. When used in this address, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, readers are cautioned not to place undue reliance on forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results may differ materially from those expressed or implied by such forward-looking statements due to various risks and uncertainties, including but not limited to regulatory approvals, market conditions, technological challenges, and competitive factors. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this information and the Company undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, contact:

Sanjeev Parsad, President and CEO
Phone: (604) 678.9115
Fax: (604) 678.9279
E-mail: sparsad@ajahw.com
Web: www.ajahw.com